Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Open accessThe DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis is a complex autoimmune disease, and several therapies for multiple sclerosis have been developed and widely used. However, existing medications for multiple sclerosis were far from satisfactory due to their failure to suppress relapses and alleviate disease progression. Novel drug targets for multiple sclerosis prevention are still needed. We performed Mendelian randomization to explore potential drug targets for multiple sclerosis using summary statistics from the International Multiple Sclerosis Genetics Consortium (nCase = 47 429, nControl = 68 374) and further replicated in UK Biobank (nCase = 1356, nControl = 395 209) and FinnGen cohorts (nCase = 1326, nControl = 359 815). Genetic instruments for 734 plasma and 154 CSF proteins were obtained from recently published genome-wide association studies. The reverse causality detection using bidirectional Mendelian randomization analysis and Steiger filtering, Bayesian co-localization, and phenotype scanning that searched previously reported genetic variant–trait associations were implemented to consolidate the Mendelian randomization findings further. In addition, the protein–protein interaction network was performed to reveal potential associations among proteins and/or present multiple sclerosis medications. At Bonferroni significance (P < 5.63 × 10−5), Mendelian randomization analysis revealed six protein–multiple sclerosis pairs. In plasma, per standard deviation increase in FCRL3, TYMP and AHSG had a protective effect. Odds ratios for the proteins above were 0.83 (95% CI, 0.79–0.89), 0.59 (95% CI, 0.48–0.71) and 0.88 (95% CI, 0.83–0.94), respectively. In CSF, per 10-fold increase in MMEL1 (OR, 5.03; 95% CI, 3.42–7.41) increased the risk of multiple sclerosis, while SLAMF7 (OR, 0.42; 95% CI, 0.29–0.60) and CD5L (OR, 0.30; 95%CI, 0.18–0.52) decreased the risk. None of the six proteins had reverse causality. Bayesian co-localization suggested that FCRL3 [coloc.abf-posterior probability of hypothesis 4 (PPH4) = 0.889], TYMP (coloc.susie-PPH4 = 0.896), AHSG (coloc.abf-PPH4 = 0.957, coloc.susie-PPH4 = 0.973), MMEL1 (coloc.abf-PPH4 = 0.930) and SLAMF7 (coloc.abf-PPH4 = 0.947) shared the same variant with multiple sclerosis. FCRL3, TYMP and SLAMF7 interacted with target proteins of current multiple sclerosis medications. MMEL1 was replicated in both UK Biobank and FinnGen cohorts. Our integrative analysis suggested that genetically determined levels of circulating FCRL3, TYMP, AHSG, CSF MMEL1 and SLAMF7 had causal effects on multiple sclerosis risk. These findings suggested those five proteins might be promising drug targets for multiple sclerosis and warrant further clinical investigation, especially FCRL3 and SLAMF7.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MR uses genetic variants as instrumental variables, providing robust causal inference and offering insight into the biological pathways driving disease progression [16,17].”
From Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization (2025) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749 · cited 1×
“28 In addition, we conducted MR by Wald ratio method and Bayesian co-localization by coloc.abf algorithm with prioritized proteins as both exposure and outcome.”
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 7×
“Finally, using the GWAS data from the UK Biobank 13 and FinnGen 14 cohorts and plasma pQTL data from two newly published studies, 15,16 we replicated the analysis as an exter-nal validation to strengthen our conclusion.”
InfluentialDrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404 · cited 1×
“27 We also searched current medications targeting the identified potential causal proteins.”
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677 · cited 1×
“23 Complete summary statistics for proteins were obtained from three previous studies.”
Giambartolomei, C., Vukcevic, D., Schadt, E. E., Franke, L., Hingorani, A. D., Wallace, C., & Plagnol, V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004383 · Cited by 4,261 · cited 1×
“…for posterior probability, five proteins identified by MR (FCRL3, TYMP, AHSG, MMEL1 and SLAMF7) were likely to share the same variant of MS. 33 Four of the five identified proteins (FCRL3, TYMP, AHSG and MMEL1) were found to be associated with other traits via phenotype scanning, but none…”
Orienting the causal relationship between imprecisely measured traits using GWAS summary data.
Hemani, G., Tilling, K., & Davey Smith, G. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007081 · Cited by 2,607 · cited 1×
“We also conducted Steiger filtering to ensure the directionality of the association between proteins and MS. 24 The results were considered statistically significant at P < 0.05.”
InfluentialGenomic atlas of the human plasma proteome
Sun, B. B., Maranville, J. C., Peters, J. E., Stacey, D., Staley, J. R., Blackshaw, J., Burgess, S., Jiang, T., Paige, E., Surendran, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0175-2 · Cited by 2,268 · cited 2×
“12,16,18 The effect was estimated using MR-IVW, MR-Egger, weighted median, simple mode and weighted mode.”
PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations
Kamat, M. A., Blackshaw, J. A., Young, R., Surendran, P., Burgess, S., Danesh, J., Butterworth, A. S., & Staley, J. R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz469 · Cited by 2,155 · cited 1×
“Phenotype scanning was conducted via both ‘phe-noscanner’ 26 and looking up in the study of Ferkingstad et al .”
Dobson, R., & Giovannoni, G. (2019) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,148
Guidelines for performing Mendelian randomization investigations
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.1 · Cited by 1,834
Cited by
Items 101–200 of 281
Meng, H., Wang, S., Gu, L., Wang, Y., Li, B., Lv, R., Xue, L., Ren, Y., Xu, L., Mao, L., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322098 · Cited by 3
“MR can discover possible therapeutic targets for various conditions, such as Alzheimer’s disease (AD) and multiple sclerosis, due to the progress in high-throughput genomic technologies and proteomics for plasma and cerebrospinal fluid (CSF) [19,20].”
Xing, S., Li, X., & Chen, C. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156945 · Cited by 4
Investigation of Novel Therapeutic Targets for Rheumatoid Arthritis Through Human Plasma Proteome
Wang, H., Huang, C., Huang, K., Wu, T., & Liu, H. (2025) · Biomedicines · doi:10.3390/biomedicines13081841 · Cited by 3
“…randomization (Pro-MR), a causality-testing framework that leverages pQTLs as instrumental variables, has provided important insights into drug target prioritization and the elucidation of disease mechanisms in conditions such as diabetes, colorectal cancer, and multiple sclerosis [11–13].”
Tian, Z., Jiang, Z., Hu, S., & Shi, L. (2023) · Medicine · doi:10.1097/md.0000000000036781 · Cited by 4
“[12] In summary, Mendelian Randomization is a powerful epidemiological tool that uses genetic variants to reveal causal relationships between exposure factors and disease outcomes.”
BackgroundPotential drug targets for tumors identified through Mendelian randomization analysis
Song, N., Shi, P., Cui, K., Zeng, L., Wang, Z., Di, W., Li, J., Fan, Y., Li, Z., Zhang, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62178-w · Cited by 3
“In recent years, MR studies have been widely employed in drug target screening and drug repurposing 14,15 .”
BackgroundLiu, X., Shi, L., Zhang, S., & Zhou, A. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001925 · Cited by 2
Liu, N., Tu, J., Yi, F., Zhang, X., Zhong, X., Wang, L., Xie, L., & Zhou, J. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04220-x · Cited by 3
Self-citationLi, X., Long, H., wen, D., Chen, B., Chen, B., & Li, B. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156736 · Cited by 3
Zhang, T., Shi, Y., Li, J., Huang, P., Chen, K., & Yao, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1448314 · Cited by 6
Gu, X., Zhao, S., Xia, M., Du, S., Song, L., Xia, T., & Zhang, B. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2432115 · Cited by 4
“13 16 In this study, based on the available genome-wide association studies (GWAS) data of peripheral blood immune cells and colorectal cancer, we performed two sample-MR with large-scale genetic variation to investigate the causal association of 731 types of immune cell phenotypes-specific changes…”
Chen, L., Fang, M.-J., Yu, X., & Xu, Y. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhae506 · Cited by 3
Self-citationThe role of ATG7-mediated ferroptosis in formaldehyde-induced ovarian injury in rats
Mao, K., Yan, H.-Z., Yang, J., Yin, Z.-X., Gao, X.-Q., Liu, H.-F., Su, H., Geng, Y.-Y., Ge, P., & Zhou, D. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.108902 · Cited by 3
Ma, J., Hou, S., Gu, X., Guo, P., & Zhu, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1533959 · Cited by 2
“With the rapid development of genome-wide association studies (GWASs), MR strategies have led to breakthroughs in therapeutic target identi fi cation for a variety of diseases (26, 27).”
The causal association between psoriasis and 32 types of cancer: a mendelian randomization study
Li, G., Tian, J., Xu, J., & Li, K. (2025) · Discover Oncology · doi:10.1007/s12672-025-02679-w · Cited by 2
“This approach isolates the causal influence of genetic predisposition to psoriasis itself, independent of environmental confounders such as therapeutic interventions [13–15].”
Zhang, W., Chen, N., Li, C., Su, X., Fu, Z., Zhong, Y., & Deng, H. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03751-5 · Cited by 2
“…genetic variants associated with protein expression levels are referred to as"protein quantitative trait loci (pQTL)", the circulating plasma protein pQTL data of this study was obtained from the study of Lin J et al. [12], which integrated five previously published GWAS data-sets [7, 13–16].”
Lu, F., Wang, G., Yang, X., Luo, J., Ma, H., Pan, L., Yao, Y., & Xie, K. (2025) · Pharmaceuticals · doi:10.3390/ph18060859 · Cited by 5
“…significantly associated with gene expression, defined by a p -value of <5 × 10 − 8 ; (3) non-linkage disequilibrium loci located within the cis-regulatory region (1 MB upstream and downstream of the gene), with r 2 < 0.001 and KB = 10,000; (4) robust IVs, indicated by an F-statistic of >10 [41].”
InfluentialBai, Y., Luo, S., Shuai, R., Zhang, X., Yuan, L., & Liu, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-04470-x · Cited by 2
Multi-omics analysis reveals the prognostic value and immunomodulatory role of CTSW in breast cancer
Liu, X., Yin, Z., Xi, P., Wang, L., & Mao, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03550-8 · Cited by 3
“MR analyses adhered to the following assumptions: the instrumental variable must be strongly associated with the exposure ( P 1 × 10 ⁻ 5), independent of the outcome, and exhibit no horizontal pleiot-ropy [42].”
Cao, C., Luo, D., Xie, X., & Dou, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-21273-2 · Cited by 2
“FCRL3, a member of the immunoglobulin receptor superfamily 22 , is a multifaceted immune regulator with dual roles in activating and inhibitory signaling 23 .”
Lin, S., Chen, Z., Cheng, J., Chen, X., Zhu, Y., Li, L., Huang, L., Chen, Y., Dai, S., & Xu, S. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04459-6 · Cited by 2
Deng, F., Peng, J., Lai, S., Zhang, G., Li, M., Huang, Y., Yuan, M., Yao, G., Zhang, P., & Lu, L. (2026) · Addiction Biology · doi:10.1111/adb.70162 · Cited by 2
“…between gene expression and alcohol dependence: PPH0 (no association with either trait), PPH1 (expression-associated only), PPH2 (outcome-associated only), PPH3 (separate causal variants for both traits) and PPH4 (shared causal variant; PPH4 > 0.80 considered significant evidence [19]).”
InfluentialChen, Z., Zheng, Z., Jiang, B., & Xu, Y. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2357246 · Cited by 2
“MR is rooted in the fundamental principles of Mendelian genetics, where genetic variations are randomly distributed in the transmission of genetic information, analogous to randomization in natural experiments [15].”
BackgroundSelf-citationDong, Q., Wu, X., Mok, T. N., Cai, G., Zha, Z., She, G., & Chen, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32406 · Cited by 2
“Expression quantitative trait loci (eQTL) analysis aids in understanding the genetic regulation of gene expression, while Mendelian randomization helps to determine the causal relationships between genes and diseases [12,13].”
Ma, M., & Zhao, Y.-S. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i26.5937 · Cited by 2
“MR uses genetic variants, typically single-nucleotide polymorphisms (SNPs) identified from genome-wide association studies (GWASs), as instrumental variables (IVs) to better evaluate exposure-outcome associations[16].”
PLASMA PROTEOME, METABOLOME MENDELIAN RANDOMIZATION IDENTIFIES SEPSIS THERAPEUTIC TARGETS
Deng, R., Huang, G., Zhou, J., & Zeng, K. (2024) · Shock · doi:10.1097/shk.0000000000002465 · Cited by 2
“In our analysis, we employed the Bonferroni correction to adjust P values, a methodknown for itsconservative approachinmitigatingtheriskoffalsepositives (29).”
Self-citationYan, J., Huai, Y., Liang, Q., Li, L., & Liao, B. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1426261 · Cited by 4
Xu, X., Miao, C., Yang, S., Xiao, L., Gao, Y., Wu, F., & Xu, J. (2024) · BioData Mining · doi:10.1186/s13040-024-00405-w · Cited by 2
“…specific criteria: (1) significant genome-wide correlation ( P < 5e − 8); (2) independent association (linkage disequilibrium (LD) set at r2 < 0.001); (3) only cis-acting pQTLs are included in this study; (4) located outside the major histocompatibility complex boundaries (CHR6, 26–34 Mb) [25].”
BackgroundInfluentialLiang, Z., Hu, C., Pang, H., Yi, S., Yao, L., & Liu, F. (2024) · Urolithiasis · doi:10.1007/s00240-024-01669-x · Cited by 2
Wang, Y., Chen, G., Deng, L., Zhang, D., & Xing, Q. (2024) · Biology Direct · doi:10.1186/s13062-024-00575-x · Cited by 3
Identifying potential drug targets for myocardial infarction through Mendelian randomization
Yu, X., & Liu, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313770 · Cited by 2
Xu, Y., Pan, Y., Wu, C., Zhao, T., Miao, J., & Ji, X. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70063 · Cited by 3
Self-citationGui, J., Chu, H., Zhang, J., Li, X., Liu, W., Li, R., Zhang, F., Dong, M., Gao, K., Luo, H., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70625 · Cited by 3
“The combination of plasma proteomics and MR has emerged as a powerful approach to elucidate disease mechanisms and identify potential drug targets (Chen et al. 2023; Lin et al. 2023; Yuan et al. 2023).”
Wang, Y., Ji, H., Chen, Y., Zhu, B., Peng, Y., & Xing, Q. (2025) · Mediators of Inflammation · doi:10.1155/mi/9648279 · Cited by 2
“Third, the PhenoScanner database was applied to systematically screen and remove SNPs associated with confounding factors [21].”
Chen, C., Xie, T., Zhang, H., Chang, L., Lan, Y., Fan, C., Wei, D., Wang, X., Liu, S., Chen, Y., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.12.24 · Cited by 2
“18 By integrating MR and colocalization analyses, we aimed to pinpoint potential causal relationships between genetic proxies of various antihypertensive drugs and AMD.”
Geng, C., & Tang, Y. (2024) · Acta Neurologica Belgica · doi:10.1007/s13760-024-02613-x · Cited by 3
Yin, K., & Chen, Y. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13652 · Cited by 2
Fan, Z., Chen, B., Ding, L., & Guo, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-80697-4 · Cited by 1
Ding, S., Tong, Q., Liu, Y., Qin, M., & Sun, S. (2025) · Bioengineering · doi:10.3390/bioengineering12020126 · Cited by 1
“…of protein genes (cis-pQTL are mainly pQTLs close to the regulated protein genes and are generally mostly located within the 1 Mb region upstream and downstream of the regulated genes); and (4) reduction of linkage disequilibrium aggregation to ensure independent associations (r 2 < 0.001) [11,12].”
InfluentialPeng, R., Wang, X., Wang, W., Li, Z., Sun, Y., & Yang, M. (2025) · Hereditas · doi:10.1186/s41065-025-00374-y · Cited by 1
Sun, H., Liu, X., Lu, J., Fan, H., Lu, D., Sun, H., Zhou, Z.-J., Li, Y., Yin, X., Song, Y., et al. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.02.011 · Cited by 1
Hu, N., Gan, J., Zhang, H., Lu, T., Tang, Q., Chen, Y., Yu, M., Ou, R., Huang, S., Zhao, H., et al. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666241280385 · Cited by 1
“15 – 17 In addition, genome-wide association study (GWAS) has made a signi fi cant contribution in identifying disease-related genetic variations (mainly single nucleotide polymorphisms, SNP), which is an effective way to understand the genetic basis of human diseases in the medical community at…”
Bi, L., Wang, J., Yang, J., Zhou, Z., Chen, K., Xu, Z., Zuo, X., Xu, J., Sheng, Y., & Cui, Y. (2025) · Clinical Proteomics · doi:10.1186/s12014-025-09544-6 · Cited by 1
“A threshold of p < 0.05/n was used to determine whether the causal association was significant [17].”
InfluentialLiu, L., Deng, L., Pan, X., Chen, J., & Yu, C. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70420 · Cited by 1
Antihypertensive Drugs and Dental Caries Risk: A Drug–Target Mendelian Randomization Analysis
Shi, W., Liu, S., Wu, X., Cheng, W., Jia, X., & Hu, Z. (2025) · International Journal of Genomics · doi:10.1155/ijog/1612322 · Cited by 1
Wang, S., Hu, H., Chen, J., & Li, C. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100327 · Cited by 2
“To evaluate the therapeutic potential of the core DEGs, we constructed a PPI network and analyzed their interactions with known SLE drug targets, aiming to identify whether these genes are functionally linked to key signaling pathways or pharmacologically actionable nodes [66].”
Zhou, Q., Gong, T., Wu, Y., Zhong, Z., Deng, H., Sun, C., Xiao, L., Ma, J., Zhu, Q., Zhu, L., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105987 · Cited by 3
Zhang, H., Li, X., Liu, Y., Li, R., Li, R., Gao, W., Wang, B., Zhang, Y., Tian, Y., Hu, X., et al. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01085-7 · Cited by 1
Yang, S., Wu, Q., & Yang, X. (2025) · Brain and Behavior · doi:10.1002/brb3.71087 · Cited by 1
“We examined whether eQTLs and PD-associated GWAS signals share a common causal variant using the coloc.abf algorithm, which estimates posterior probabilities for five mutually exclusive hypotheses (PPH0–PPH4) (Lin et al. 2023).”
Zeng, L., Zhang, J., Liu, X., Yang, X., & Nie, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-04173-9 · Cited by 1
“Bayesian colocalization analysis was then performed to identify shared risk loci between IBD and breast cancer comorbidity [21].”
Jiang, Y., Guan, Z., Yao, X., Liu, X., Qiu, D., Sun, B., & Li, H. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70073 · Cited by 1
Feng, Y., Xv, Y., Shan, J., Guo, E., Lin, J., Pan, H., Dong, M., & Mo, J. (2026) · Current Medicinal Chemistry · doi:10.2174/0109298673381624251020065846 · Cited by 2
Self-citationZheng, D., Gu, J., Nao, J., Sun, M., & Dong, X. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03727-0 · Cited by 1
“A significance threshold of PPH4 > 0.80 was established for colocalization, with genes demonstrating colocalization with AD considered potential drug targets [32].”
InfluentialYu, Y., Wang, L., Wang, T., Zhang, Y., Su, X., Dai, X., & Mo, X. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10757-9 · Cited by 1
Yan, J., Yu, S., Gao, Y., Cai, J., Deng, Z., Yu, J. H., & Liu, Q. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1766780 · Cited by 1
Gao, N., Li, J., Wei, T., Cheng, Q., Gao, S., & Hu, Y. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.111987 · Cited by 1
Wang, L., Zhang, C., Tian, L., Huang, J., Jia, L.-J., Tao, H., Yu, N.-W., & Li, B.-H. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10124-0 · Cited by 1
“By mitigating confounding effects, MR enhances causal inference, making it a robust tool in clinical research (Lin et al. 2023).”
Mao, X., Lu, X., Liu, Y., Wu, H., Li, B., & Bi, X. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106440 · Cited by 1
Zhang, Y., Meng, X., & Li, M. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2542530 · Cited by 2
Peng, L., Peng, H., Wu, N., Wang, X., Li, H., & Ding, X. (2025) · Neurosurgical Review · doi:10.1007/s10143-025-03870-x · Cited by 1
Islam, T., García‐Marín, L. M., Rentería, M. E., Cuéllar-Partida, G., Khan, A., Zeng, J., & Moni, M. A. (2023) · medRxiv · doi:10.1101/2023.03.08.23287006 · Cited by 1
Sobczyk, M. K., & Gaunt, T. R. (2023) · medRxiv · doi:10.1101/2023.10.02.23296427 · Cited by 1
Geng, J., Chen, L., Yang, C.-S., Ruan, X., Hu, S., Chen, J., & Wu, Z. (2023) · medRxiv · doi:10.1101/2023.11.22.23298887 · Cited by 1
Ma, X.-L., Zhao, Q., Xu, Q., Song, Z.-T., Bu, F., Li, K., Zhang, L., & Pei, Y. (2024) · doi:10.22541/au.170664373.39572720/v1
Zhang, T. (2024) · Research Square · doi:10.21203/rs.3.rs-4157703/v1 · Cited by 1
Multi-omics integration prioritizes potential drug targets for multiple sclerosisPreprint
Jiang, Y., Liu, Q., Stridh, P., Kockum, I. S., Olsson, T. P., Alfredsson, L. S., Díaz-Gallo, L.-M., & Jiang, X. (2024) · medRxiv · doi:10.1101/2024.09.26.24314450 · Cited by 1
Hu, X., Li, M., Wang, Z., Bi, L., & Wang, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4495137
Feng, Y., & Shen, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3402538/v1
Xiong, Z., Ning, W., & Li, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3407808/v1
Cai, Y., Wang, X., Yuan, Q., & Xu, P. (2023) · Research Square · doi:10.21203/rs.3.rs-3438026/v1
Network-based biomarker discovery for multiple sclerosis
Åkesson, J. (2023) · Linköping studies in science and technology. Dissertations · doi:10.3384/9789180753968
Membranous Nephropathy: Muti-omics Mendelian randomization and colocalization analysisPreprint
Su, Z., Liu, W., Yin, Z., Wu, D., Cheng, Y. S., & Wan, Q. (2023) · medRxiv · doi:10.1101/2023.11.21.23298831
Guo, Z., Ye, W., Wang, J., & Lv, W. (2023) · Research Square · doi:10.21203/rs.3.rs-3614534/v1
Hu, X., Hua, D., Li, M., Wang, Z., Bi, L., Feng, Y., & Wang, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4647882
Su, Z., Rao, Q., Wu, D., Yin, Z., Liu, W., & Wan, Q. (2023) · medRxiv · doi:10.1101/2023.12.11.23299722
COVID-19 and membranous nephropathy: observational and Mendelian randomization analysesPreprint
Liu, W., Su, Z., Yin, Z., Wu, D., Cheng, Y. S., Hu, H., Xue, R., Tao, C., Xu, H., Zhang, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3753145/v1
Zhu, X., Qiu, Z., Yang, M., Kong, L., Li, L., Huang, Y., & Xie, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3908572/v1
Zhang, S., Hu, X., Hou, D., Sun, X., & Sun, D. (2024) · medRxiv · doi:10.1101/2024.03.29.24305070 · Cited by 1
From genomic insights to clinical hope: Targeting NEU1 in IgA nephropathy
Zhao, C., Zhang, M., Zhao, L., & Sun, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112051
Causality between Diabetes and MN: Mendelian randomization and meta-analysisPreprint
Su, Z., Luo, Z., Wu, D., Liu, W., Li, W., Yin, Z., Xue, R., Wu, L., Cheng, Y. Z., & Wan, Q. (2024) · medRxiv · doi:10.1101/2024.04.25.24306363
“MR is an analytical method to infer causal relationships between exposures and outcomes(14).”
MethodGenome-wide Mendelian Randomization Identifies Potential Drug Targets for DorsopathiesPreprint
Cui, Y., Guo, J., Lu, Y., Hu, M., Zhou, H., Zhang, W., & Tang, S. (2024) · medRxiv · doi:10.1101/2024.05.01.24306675
“Previous studies have successfully utilized MR to identify biomarkers and treatment targets for various diseases, such as aortic aneurysms [12], multiple sclerosis [13], and breast cancer [14].”
Zhang, Z., Cao, B., & Wu, Q. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0030
“40 We further developed an instrumental variable by identifying SNPs within a 100 kb window of the NAT8 gene, which are genome-wide signi fi cantly ( P 5E-8) associated with N -acetylornithine levels, to serve as proxies for the exposure to potential target drugs.”
Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals
Özkan, M., Yüksel, T. N., & Tozoğlu, F. (2024) · Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.21597/jist.1402305 · Cited by 1
Resting CD4 regulatory T cell and neuroblastoma: A Mendelian randomization study
Wang, R., & Wang, S. (2024) · Pediatric Discovery · doi:10.1002/pdi3.85
“24 We conducted co‐localization analysis to identify whether the NB phenotype and corresponding inflammatory cytokine phenotype are driven by the same causal variation in a certain region in order to confirm the evidence of a correlation between the two phenotypes.”
Yi, G., Zhengran, L., Sun, Y., Ma, X., Wang, Z., Chen, J., Cai, D., Zhang, Z., Chen, Z., Wu, F., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4872349
Chen, Y., Zhang, H., Lu, Y.-X., Lao, L., Dai, S., & Li, J. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4883985
SPOCK2, a novel potential target for cereal intake in knee osteoarthritis
Li, E., Sun, J., Zheng, H., Wang, J., & Xu, P. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250212
“In previous studies, MR has been successfully used to proof the causality of food intake and morning diurnal preference [17], to analyze the causes of KOA [18], and to identify potential drug targets for multiple sclerosis in plasma [19].”
Chen, X., Shi, K., Zheng, Y., Tian, W., Qi, Y., Zhang, N., Wang, X., & Tian, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4541424/v1
Zhang, Q., An, N., Li, X., Zhang, P., Wang, K., & Zha, B. (2024) · Research Square · doi:10.21203/rs.3.rs-4735688/v1
Xiao, Z., Zheng, N., Chen, H., Yang, Z., Wang, R., & Liang, Z. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03056-x · Cited by 1
“In this study, we tested the posterior probability of hypothesis 4 (PPH4), and evidence of exposure and outcome variation co-localization was considered when PPH4> 80% [27, 28].”
MethodCheng, L., Gan, S., Huang, P., Zhang, Q., Kang, S., Han, L., Zhang, P., Zhan, M., Wu, X., Huang, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4954410/v1
Multi-Omics Integration Prioritizes Potential Drug Targets for Multiple SclerosisPreprint
Jiang, Y., Liu, Q., Stridh, P., Kockum, I. S., Olsson, T. P., Alfredsson, L. S., Díaz-Gallo, L.-M., & Jiang, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4948512
Chen, X., Wu, J., Xu, X., Zhang, D., Dong, Q., Lai, W., Shi, C., & Luo, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4898009/v1
Xu, Q., Li, M., Wang, Z., Jiao, J., Yang, L., Jiang, W., Yu, T., Wang, Y., & Wu, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4932871/v1
Xie, W., Zheng, J., Kong, C., Luo, W., Lin, X. N., & Zhou, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111208
Li, W., Ma, S., & Tian, Y. (2025) · Health Science Reports · doi:10.1002/hsr2.70528
“The MR approach, which is powerful in inferring causality, relies on the assumption that the genetic variants used as instruments are not associated with confounding factors [104].”
Shi, X., Tang, L., Li, M., Wei, M., Wu, Y., & Xu, Y. (2025) · Molecular Biotechnology · doi:10.1007/s12033-025-01416-6 · Cited by 1
Self-citationTan, H., Chen, H., Yan, H., Li, F., Yao, Y., Li, Y., & Qian, F. (2025) · Neurological Research · doi:10.1080/01616412.2025.2487867
“The analytical framework calculates posterior probabilities for five distinct hypotheses regarding genetic locus sharing, as established in prior methodological research [34].”
Li, R., Lei, Z., Wen, Z.-K., Zhou, Y., Ma, Y., Qin, J., Huang, X., Huang, S., Peng, S., Liang, S.-J., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02237-4
“[24].”
Xie, J., Zhang, Y., Ren, R., Bu, R., Chen, L., Hou, J., Shang, D., Liu, Y., Wang, D., Wang, T., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18050618
Genetic Analysis Reveals a Protective Effect of Sphingomyelin on Cholelithiasis
Mao, K., Li, A., Liu, H., Gao, Y., Wang, Z., Wang, X., Liu, S., Gao, Z., Quan, J., Shao, M., et al. (2025) · Genes · doi:10.3390/genes16050523
“By employing single-nucleotide polymorphisms (SNPs) from genome-wide association studies (GWAS) as instrumental variables (IVs) for exposure, MR controls confounding factors and avoids reverse causation, strengthening causal inferences [6–9].”
Metadata
- Authors
- Lin, J., Zhou, J., & Xu, Y.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Xu, Yan
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-03-02
- Volume
- 146
- Issue
- 8
- Pages
- 3364-3372
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC10393411
- OpenAlex
- W4323035146
- Cited by
- 271
- References
- 56
- Citations by year
- 2026: 43 · 2025: 87 · 2024: 120 · 2023: 21
- FWCI
- 55.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Peking Union Medical College Deposition Research Fund (ZC201904188)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- multiple sclerosis, therapeutic target, plasma proteins, cerebrospinal fluid protein, FCRL3, SLAMF7, CD5L, fetuin-A, thymidine phosphorylase, reverse causality, protein-protein interaction network, autoimmune disease, genetic risk factors, disease progression, relapse prevention, neuroinflammation, neurodegeneration
- MeSH terms
- Bayes Theorem, Humans, Multiple Sclerosis, Phenotype, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.